Metabolic syndrome in patients with ischemic heart disease

Samra Yasmin1, Nadeem Hayat Mallick, Tahir Naveed

  • 1Department of Cardiology, Punjab Institute of Cardiology, Lahore. samarmateen4@hotmail.com

Insights

Metabolic syndrome is common in patients with Ischemic Heart Disease (IHD). This study found a high frequency of metabolic syndrome in IHD patients, highlighting the need for preventive strategies.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Epidemiology

Background:

  • Ischemic Heart Disease (IHD) is a leading cause of mortality worldwide.
  • Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.
  • Understanding the prevalence of metabolic syndrome in IHD patients is crucial for risk stratification and management.

Purpose of the Study:

  • To determine the frequency of metabolic syndrome in patients diagnosed with Ischemic Heart Disease (IHD).

Main Methods:

  • A cross-sectional, descriptive study was conducted.
  • 100 patients with IHD were enrolled from the Punjab Institute of Cardiology.
  • Data on demographic factors, metabolic syndrome components (including waist circumference, blood glucose, and lipid profiles), and diagnosis (STEMI) were collected and analyzed.

Main Results:

  • The study population comprised 68% males and 32% females, with a mean age of 52 years for men and 56 years for women.
  • The overall frequency of metabolic syndrome was 32% in men and 28% in women.
  • Metabolic syndrome prevalence increased with age, and was notably higher in men diagnosed with STEMI (ST-elevation myocardial infarction).

Conclusions:

  • A significant proportion of patients with Ischemic Heart Disease also have metabolic syndrome.
  • These findings underscore the importance of screening for and managing metabolic syndrome in IHD patients.
  • Preventive interventions targeting metabolic syndrome components may reduce cardiovascular risk in high-risk populations.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...